From pixels to pathways—the future of integrated diagnostics

IN THIS EPISODE:

• [0:54] Fredrik provides information about his education and work experience
• [1:47] Prabs discusses his background and the relationship between Genomics England and Sectra
• [6:03] The reason Sectra established a Genomics IT business unit
• [8:22] The definition of genomics in terms of cancer and diagnostics, as well as clinical and research perspectives
• [14:07] The capabilities of Sectra’s genomics solution
• [17.39] Genomics England’s initiatives and the potential that comes from integrating this data
• [21:27] Integration of genomics within the clinical workflow, and the influence of genetic data utilization on diagnosis, treatment planning, and patient outcomes
• [25:26] Sectra Genomics launch and update on the Penn Medicine pilot project
• [27:35] What genomics might look like in ten years and what impact it might have on healthcare

KEY TAKEAWAYS:

• Sectra launched a new Genomics IT business unit dedicated to innovation and product development to help customers in working efficiently in a molecular diagnostic setting.
• Sectra’s genomics solution will bring radiology, digital pathology, and genomic data together on a single platform to take integrated diagnostics to the next level.
• The convergence of data from radiology, digital pathology, and genomic data has the potential to significantly improve patient care and precision medicine.